Novo Nordisk AS (OCSE:NOVO B)
kr 757.3 9.7 (1.3%) Market Cap: 3.36 Til Enterprise Value: 3.35 Til PE Ratio: 35.72 PB Ratio: 27.97 GF Score: 97/100

Q1 2021 Novo Nordisk A/S Earnings Call Transcript

May 05, 2021 / 11:00AM GMT
Release Date Price: kr229.63 (+0.35%)
Operator

Hello, and welcome to the Q1 2021 Novo Nordisk A/S earnings conference call. (Operator Instructions) Today, I'm pleased to present Lars Fruergaard Jørgensen. Please go ahead with your meeting.

Lars Fruergaard Jorgensen;S;President
Novo Nordisk A;CEO & Member of Management Board

/- -

Thank you very much, and welcome to this Novo Nordisk Earnings Call for the first 3 months of 2021 and outlook for the year. I'm Lars Fruergaard Jørgensen, the CEO of Novo Nordisk. With me I have our Chief Financial Officer, Karsten Munk Knudsen; and Executive Vice President and Head of Development, Martin Holtz Lange. Also present and available for Q&A session is Executive Vice President and Head of Commercial Strategy and Corporate Affairs, Camilla Sylvest.

Today's earnings release and the slides for this call are available on our website, novonordisk.com. Please note that this call is being webcasted live and this call -- and the recording will be made available on Novo Nordisk's website. The call is scheduled to last 1

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot